Parent and Infant Inter(X)Action Intervention (PIXI)
Launched by RTI INTERNATIONAL · Feb 7, 2019
Trial Information
Current as of November 06, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Researchers are testing a new early-support program called PIXI (Parent-Infant Inter(X)action Intervention) for infants who have a confirmed, rare neurogenetic disorder and developmental delays or intellectual disability. PIXI runs during the baby’s first year and combines: education about the diagnosed condition and early development, help finding and using services, activities to support parent–child interaction, coaching for parents, and support for the family’s well-being. This is a single-group study (no comparison group) to see if the program is feasible, acceptable to families, and potentially helpful for both the child and the family.
To participate, infants must be 15 months old or younger and have a diagnosed rare neurogenetic disorder (examples include Fragile X, Angelman, Prader-Willi, Dup15q, Phelan-McDermid, Rett, Williams, Turner, Down syndrome, Duchenne muscular dystrophy, and others). English must be the primary language spoken at home, and the child cannot be blind or have a severe hearing impairment. About 120 families are being invited to join at sites like RTI International in North Carolina. Participants will receive PIXI across two phases with about 20 sessions in total, and researchers will look at family satisfaction, how well the program is carried out, and the child’s development and autism-related symptoms over time (through about age 3). The study is currently enrolling, with completion expected around 2026–2027.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants 15 months of age or younger who have received a diagnosis which was not sought solely due to parental concerns about the infant (e.g. diagnosis due to prenatal or newborn screening, cascade testing following diagnosis of a family member).
- • English must be the primary language spoken in the home because all assessment measures and intervention protocol are in English.
- Exclusion Criteria:
- • - Infants may not be blind or have a severe hearing impairment as the intervention and assessments are not appropriate for these children.
About Rti International
RTI International is a leading nonprofit research institute dedicated to improving the human condition through innovative scientific research and technical assistance. With a strong focus on health and social science, RTI collaborates with various stakeholders, including government agencies, private organizations, and academic institutions, to advance knowledge and drive impactful solutions. The organization is recognized for its rigorous methodologies and commitment to ethical research practices, making it a trusted sponsor for clinical trials aimed at enhancing public health and advancing medical science. Through its comprehensive approach, RTI International contributes to the development of evidence-based strategies that address pressing health challenges globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Research Triangle Park, North Carolina, United States
Patients applied
Trial Officials
Anne Wheeler, PhD
Principal Investigator
RTI International
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials